Excretion of Ascaris lumbricoides following reduced-intensity allogeneic hematopoietic stem cell transplantation and consecutive treatment with mebendazole.
Identifieur interne : 000122 ( Main/Exploration ); précédent : 000121; suivant : 000123Excretion of Ascaris lumbricoides following reduced-intensity allogeneic hematopoietic stem cell transplantation and consecutive treatment with mebendazole.
Auteurs : Verena Luber [Allemagne] ; Mathias Lutz [Allemagne] ; Marianne Abele-Horn [Allemagne] ; Hermann Einsele [Allemagne] ; Götz Ulrich Grigoleit [Allemagne] ; Stephan Mielke [Allemagne, Suède]Source :
- Transplant infectious disease : an official journal of the Transplantation Society [ 1399-3062 ] ; 2020.
Descripteurs français
- KwdFr :
- Adulte d'âge moyen (MeSH), Animaux (MeSH), Ascaridiose (diagnostic), Ascaris lombricoides (MeSH), Conditionnement pour greffe (MeSH), Fèces (parasitologie), Humains (MeSH), Myélome multiple (parasitologie), Myélome multiple (thérapie), Mâle (MeSH), Mébendazole (usage thérapeutique), Numération des oeufs de parasites (MeSH), Transplantation de cellules souches (MeSH), Transplantation de cellules souches hématopoïétiques (MeSH), Transplantation homologue (MeSH), Égypte (MeSH).
- MESH :
- diagnostic : Ascaridiose.
- parasitologie : Fèces, Myélome multiple.
- thérapie : Myélome multiple.
- usage thérapeutique : Mébendazole.
- Adulte d'âge moyen, Animaux, Ascaris lombricoides, Conditionnement pour greffe, Humains, Mâle, Numération des oeufs de parasites, Transplantation de cellules souches, Transplantation de cellules souches hématopoïétiques, Transplantation homologue, Égypte.
- Wicri :
- geographic : Égypte.
English descriptors
- KwdEn :
- Animals (MeSH), Ascariasis (diagnosis), Ascaris lumbricoides (MeSH), Egypt (MeSH), Feces (parasitology), Hematopoietic Stem Cell Transplantation (MeSH), Humans (MeSH), Male (MeSH), Mebendazole (therapeutic use), Middle Aged (MeSH), Multiple Myeloma (parasitology), Multiple Myeloma (therapy), Parasite Egg Count (MeSH), Stem Cell Transplantation (MeSH), Transplantation Conditioning (MeSH), Transplantation, Homologous (MeSH).
- MESH :
- chemical , therapeutic use : Mebendazole.
- geographic : Egypt.
- diagnosis : Ascariasis.
- parasitology : Feces, Multiple Myeloma.
- therapy : Multiple Myeloma.
- Animals, Ascaris lumbricoides, Hematopoietic Stem Cell Transplantation, Humans, Male, Middle Aged, Parasite Egg Count, Stem Cell Transplantation, Transplantation Conditioning, Transplantation, Homologous.
Abstract
Here, we present the unique case of a 51-year-old German patient with multiple myeloma excreting Ascaris lumbricoides in his stool five weeks after allogeneic hematopoietic stem cell transplantation. Stool analysis remained negative for the presence of eggs, and there was no eosinophilia in the peripheral blood at any time around stem cell transplantation. The patient was commenced on a three-day treatment with mebendazole, which was well tolerated. No serious interactions with the concomitant post-transplant medication or negative effects on the hematopoiesis were observed, and the myeloma still is in complete remission. To our knowledge, this is the first report on excretion of A lumbricoides in the context of allogeneic stem cell transplantation. The case is remarkable with view to the fact that the parasite has supposedly survived all courses of myeloma treatment including autologous and allogeneic conditioning. Parasitosis with A lumbricoides has a worldwide prevalence of about a billion and is extremely rare in northern Europe. Possibly the patient got infected during a trip to Egypt years before multiple myeloma was diagnosed.
DOI: 10.1111/tid.13224
PubMed: 31782899
Affiliations:
- Allemagne, Suède
- Bavière, District de Basse-Franconie, District de Münster, Rhénanie-du-Nord-Westphalie, Svealand
- Münster, Stockholm, Wurtzbourg
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Excretion of Ascaris lumbricoides following reduced-intensity allogeneic hematopoietic stem cell transplantation and consecutive treatment with mebendazole.</title><author><name sortKey="Luber, Verena" sort="Luber, Verena" uniqKey="Luber V" first="Verena" last="Luber">Verena Luber</name><affiliation wicri:level="3"><nlm:affiliation>Department of Internal Medicine II, University Hospital of Würzburg, Würzburg, Germany.</nlm:affiliation><country xml:lang="fr">Allemagne</country><wicri:regionArea>Department of Internal Medicine II, University Hospital of Würzburg, Würzburg</wicri:regionArea><placeName><region type="land" nuts="1">Bavière</region><region type="district" nuts="2">District de Basse-Franconie</region><settlement type="city">Wurtzbourg</settlement></placeName></affiliation><affiliation wicri:level="1"><nlm:affiliation>Department of Hematology and Oncology, Sana Hospital Hof, Hof, Germany.</nlm:affiliation><country xml:lang="fr">Allemagne</country><wicri:regionArea>Department of Hematology and Oncology, Sana Hospital Hof, Hof</wicri:regionArea><wicri:noRegion>Hof</wicri:noRegion><wicri:noRegion>Hof</wicri:noRegion><wicri:noRegion>Hof</wicri:noRegion></affiliation></author><author><name sortKey="Lutz, Mathias" sort="Lutz, Mathias" uniqKey="Lutz M" first="Mathias" last="Lutz">Mathias Lutz</name><affiliation wicri:level="3"><nlm:affiliation>Department of Internal Medicine II, University Hospital of Würzburg, Würzburg, Germany.</nlm:affiliation><country xml:lang="fr">Allemagne</country><wicri:regionArea>Department of Internal Medicine II, University Hospital of Würzburg, Würzburg</wicri:regionArea><placeName><region type="land" nuts="1">Bavière</region><region type="district" nuts="2">District de Basse-Franconie</region><settlement type="city">Wurtzbourg</settlement></placeName></affiliation><affiliation wicri:level="3"><nlm:affiliation>Department of Medicine A, University Hospital of Münster, Münster, Germany.</nlm:affiliation><country xml:lang="fr">Allemagne</country><wicri:regionArea>Department of Medicine A, University Hospital of Münster, Münster</wicri:regionArea><placeName><region type="land" nuts="1">Rhénanie-du-Nord-Westphalie</region><region type="district" nuts="2">District de Münster</region><settlement type="city">Münster</settlement></placeName></affiliation></author><author><name sortKey="Abele Horn, Marianne" sort="Abele Horn, Marianne" uniqKey="Abele Horn M" first="Marianne" last="Abele-Horn">Marianne Abele-Horn</name><affiliation wicri:level="3"><nlm:affiliation>Institute for Hygiene and Microbiology, University of Würzburg, Würzburg, Germany.</nlm:affiliation><country xml:lang="fr">Allemagne</country><wicri:regionArea>Institute for Hygiene and Microbiology, University of Würzburg, Würzburg</wicri:regionArea><placeName><region type="land" nuts="1">Bavière</region><region type="district" nuts="2">District de Basse-Franconie</region><settlement type="city">Wurtzbourg</settlement></placeName></affiliation></author><author><name sortKey="Einsele, Hermann" sort="Einsele, Hermann" uniqKey="Einsele H" first="Hermann" last="Einsele">Hermann Einsele</name><affiliation wicri:level="3"><nlm:affiliation>Department of Internal Medicine II, University Hospital of Würzburg, Würzburg, Germany.</nlm:affiliation><country xml:lang="fr">Allemagne</country><wicri:regionArea>Department of Internal Medicine II, University Hospital of Würzburg, Würzburg</wicri:regionArea><placeName><region type="land" nuts="1">Bavière</region><region type="district" nuts="2">District de Basse-Franconie</region><settlement type="city">Wurtzbourg</settlement></placeName></affiliation></author><author><name sortKey="Grigoleit, Gotz Ulrich" sort="Grigoleit, Gotz Ulrich" uniqKey="Grigoleit G" first="Götz Ulrich" last="Grigoleit">Götz Ulrich Grigoleit</name><affiliation wicri:level="3"><nlm:affiliation>Department of Internal Medicine II, University Hospital of Würzburg, Würzburg, Germany.</nlm:affiliation><country xml:lang="fr">Allemagne</country><wicri:regionArea>Department of Internal Medicine II, University Hospital of Würzburg, Würzburg</wicri:regionArea><placeName><region type="land" nuts="1">Bavière</region><region type="district" nuts="2">District de Basse-Franconie</region><settlement type="city">Wurtzbourg</settlement></placeName></affiliation></author><author><name sortKey="Mielke, Stephan" sort="Mielke, Stephan" uniqKey="Mielke S" first="Stephan" last="Mielke">Stephan Mielke</name><affiliation wicri:level="3"><nlm:affiliation>Department of Internal Medicine II, University Hospital of Würzburg, Würzburg, Germany.</nlm:affiliation><country xml:lang="fr">Allemagne</country><wicri:regionArea>Department of Internal Medicine II, University Hospital of Würzburg, Würzburg</wicri:regionArea><placeName><region type="land" nuts="1">Bavière</region><region type="district" nuts="2">District de Basse-Franconie</region><settlement type="city">Wurtzbourg</settlement></placeName></affiliation><affiliation wicri:level="3"><nlm:affiliation>CAST, Department of Laboratory Medicine and Medicine Huddinge, Karolinska Institutet and University Hospital, Stockholm, Sweden.</nlm:affiliation><country xml:lang="fr">Suède</country><wicri:regionArea>CAST, Department of Laboratory Medicine and Medicine Huddinge, Karolinska Institutet and University Hospital, Stockholm</wicri:regionArea><placeName><settlement type="city">Stockholm</settlement><region nuts="2">Svealand</region></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:31782899</idno><idno type="pmid">31782899</idno><idno type="doi">10.1111/tid.13224</idno><idno type="wicri:Area/Main/Corpus">000152</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000152</idno><idno type="wicri:Area/Main/Curation">000152</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000152</idno><idno type="wicri:Area/Main/Exploration">000152</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Excretion of Ascaris lumbricoides following reduced-intensity allogeneic hematopoietic stem cell transplantation and consecutive treatment with mebendazole.</title><author><name sortKey="Luber, Verena" sort="Luber, Verena" uniqKey="Luber V" first="Verena" last="Luber">Verena Luber</name><affiliation wicri:level="3"><nlm:affiliation>Department of Internal Medicine II, University Hospital of Würzburg, Würzburg, Germany.</nlm:affiliation><country xml:lang="fr">Allemagne</country><wicri:regionArea>Department of Internal Medicine II, University Hospital of Würzburg, Würzburg</wicri:regionArea><placeName><region type="land" nuts="1">Bavière</region><region type="district" nuts="2">District de Basse-Franconie</region><settlement type="city">Wurtzbourg</settlement></placeName></affiliation><affiliation wicri:level="1"><nlm:affiliation>Department of Hematology and Oncology, Sana Hospital Hof, Hof, Germany.</nlm:affiliation><country xml:lang="fr">Allemagne</country><wicri:regionArea>Department of Hematology and Oncology, Sana Hospital Hof, Hof</wicri:regionArea><wicri:noRegion>Hof</wicri:noRegion><wicri:noRegion>Hof</wicri:noRegion><wicri:noRegion>Hof</wicri:noRegion></affiliation></author><author><name sortKey="Lutz, Mathias" sort="Lutz, Mathias" uniqKey="Lutz M" first="Mathias" last="Lutz">Mathias Lutz</name><affiliation wicri:level="3"><nlm:affiliation>Department of Internal Medicine II, University Hospital of Würzburg, Würzburg, Germany.</nlm:affiliation><country xml:lang="fr">Allemagne</country><wicri:regionArea>Department of Internal Medicine II, University Hospital of Würzburg, Würzburg</wicri:regionArea><placeName><region type="land" nuts="1">Bavière</region><region type="district" nuts="2">District de Basse-Franconie</region><settlement type="city">Wurtzbourg</settlement></placeName></affiliation><affiliation wicri:level="3"><nlm:affiliation>Department of Medicine A, University Hospital of Münster, Münster, Germany.</nlm:affiliation><country xml:lang="fr">Allemagne</country><wicri:regionArea>Department of Medicine A, University Hospital of Münster, Münster</wicri:regionArea><placeName><region type="land" nuts="1">Rhénanie-du-Nord-Westphalie</region><region type="district" nuts="2">District de Münster</region><settlement type="city">Münster</settlement></placeName></affiliation></author><author><name sortKey="Abele Horn, Marianne" sort="Abele Horn, Marianne" uniqKey="Abele Horn M" first="Marianne" last="Abele-Horn">Marianne Abele-Horn</name><affiliation wicri:level="3"><nlm:affiliation>Institute for Hygiene and Microbiology, University of Würzburg, Würzburg, Germany.</nlm:affiliation><country xml:lang="fr">Allemagne</country><wicri:regionArea>Institute for Hygiene and Microbiology, University of Würzburg, Würzburg</wicri:regionArea><placeName><region type="land" nuts="1">Bavière</region><region type="district" nuts="2">District de Basse-Franconie</region><settlement type="city">Wurtzbourg</settlement></placeName></affiliation></author><author><name sortKey="Einsele, Hermann" sort="Einsele, Hermann" uniqKey="Einsele H" first="Hermann" last="Einsele">Hermann Einsele</name><affiliation wicri:level="3"><nlm:affiliation>Department of Internal Medicine II, University Hospital of Würzburg, Würzburg, Germany.</nlm:affiliation><country xml:lang="fr">Allemagne</country><wicri:regionArea>Department of Internal Medicine II, University Hospital of Würzburg, Würzburg</wicri:regionArea><placeName><region type="land" nuts="1">Bavière</region><region type="district" nuts="2">District de Basse-Franconie</region><settlement type="city">Wurtzbourg</settlement></placeName></affiliation></author><author><name sortKey="Grigoleit, Gotz Ulrich" sort="Grigoleit, Gotz Ulrich" uniqKey="Grigoleit G" first="Götz Ulrich" last="Grigoleit">Götz Ulrich Grigoleit</name><affiliation wicri:level="3"><nlm:affiliation>Department of Internal Medicine II, University Hospital of Würzburg, Würzburg, Germany.</nlm:affiliation><country xml:lang="fr">Allemagne</country><wicri:regionArea>Department of Internal Medicine II, University Hospital of Würzburg, Würzburg</wicri:regionArea><placeName><region type="land" nuts="1">Bavière</region><region type="district" nuts="2">District de Basse-Franconie</region><settlement type="city">Wurtzbourg</settlement></placeName></affiliation></author><author><name sortKey="Mielke, Stephan" sort="Mielke, Stephan" uniqKey="Mielke S" first="Stephan" last="Mielke">Stephan Mielke</name><affiliation wicri:level="3"><nlm:affiliation>Department of Internal Medicine II, University Hospital of Würzburg, Würzburg, Germany.</nlm:affiliation><country xml:lang="fr">Allemagne</country><wicri:regionArea>Department of Internal Medicine II, University Hospital of Würzburg, Würzburg</wicri:regionArea><placeName><region type="land" nuts="1">Bavière</region><region type="district" nuts="2">District de Basse-Franconie</region><settlement type="city">Wurtzbourg</settlement></placeName></affiliation><affiliation wicri:level="3"><nlm:affiliation>CAST, Department of Laboratory Medicine and Medicine Huddinge, Karolinska Institutet and University Hospital, Stockholm, Sweden.</nlm:affiliation><country xml:lang="fr">Suède</country><wicri:regionArea>CAST, Department of Laboratory Medicine and Medicine Huddinge, Karolinska Institutet and University Hospital, Stockholm</wicri:regionArea><placeName><settlement type="city">Stockholm</settlement><region nuts="2">Svealand</region></placeName></affiliation></author></analytic><series><title level="j">Transplant infectious disease : an official journal of the Transplantation Society</title><idno type="eISSN">1399-3062</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals (MeSH)</term><term>Ascariasis (diagnosis)</term><term>Ascaris lumbricoides (MeSH)</term><term>Egypt (MeSH)</term><term>Feces (parasitology)</term><term>Hematopoietic Stem Cell Transplantation (MeSH)</term><term>Humans (MeSH)</term><term>Male (MeSH)</term><term>Mebendazole (therapeutic use)</term><term>Middle Aged (MeSH)</term><term>Multiple Myeloma (parasitology)</term><term>Multiple Myeloma (therapy)</term><term>Parasite Egg Count (MeSH)</term><term>Stem Cell Transplantation (MeSH)</term><term>Transplantation Conditioning (MeSH)</term><term>Transplantation, Homologous (MeSH)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte d'âge moyen (MeSH)</term><term>Animaux (MeSH)</term><term>Ascaridiose (diagnostic)</term><term>Ascaris lombricoides (MeSH)</term><term>Conditionnement pour greffe (MeSH)</term><term>Fèces (parasitologie)</term><term>Humains (MeSH)</term><term>Myélome multiple (parasitologie)</term><term>Myélome multiple (thérapie)</term><term>Mâle (MeSH)</term><term>Mébendazole (usage thérapeutique)</term><term>Numération des oeufs de parasites (MeSH)</term><term>Transplantation de cellules souches (MeSH)</term><term>Transplantation de cellules souches hématopoïétiques (MeSH)</term><term>Transplantation homologue (MeSH)</term><term>Égypte (MeSH)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Mebendazole</term></keywords><keywords scheme="MESH" type="geographic" xml:lang="en"><term>Egypt</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Ascariasis</term></keywords><keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Ascaridiose</term></keywords><keywords scheme="MESH" qualifier="parasitologie" xml:lang="fr"><term>Fèces</term><term>Myélome multiple</term></keywords><keywords scheme="MESH" qualifier="parasitology" xml:lang="en"><term>Feces</term><term>Multiple Myeloma</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Multiple Myeloma</term></keywords><keywords scheme="MESH" qualifier="thérapie" xml:lang="fr"><term>Myélome multiple</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Mébendazole</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Animals</term><term>Ascaris lumbricoides</term><term>Hematopoietic Stem Cell Transplantation</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Parasite Egg Count</term><term>Stem Cell Transplantation</term><term>Transplantation Conditioning</term><term>Transplantation, Homologous</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte d'âge moyen</term><term>Animaux</term><term>Ascaris lombricoides</term><term>Conditionnement pour greffe</term><term>Humains</term><term>Mâle</term><term>Numération des oeufs de parasites</term><term>Transplantation de cellules souches</term><term>Transplantation de cellules souches hématopoïétiques</term><term>Transplantation homologue</term><term>Égypte</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Égypte</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Here, we present the unique case of a 51-year-old German patient with multiple myeloma excreting Ascaris lumbricoides in his stool five weeks after allogeneic hematopoietic stem cell transplantation. Stool analysis remained negative for the presence of eggs, and there was no eosinophilia in the peripheral blood at any time around stem cell transplantation. The patient was commenced on a three-day treatment with mebendazole, which was well tolerated. No serious interactions with the concomitant post-transplant medication or negative effects on the hematopoiesis were observed, and the myeloma still is in complete remission. To our knowledge, this is the first report on excretion of A lumbricoides in the context of allogeneic stem cell transplantation. The case is remarkable with view to the fact that the parasite has supposedly survived all courses of myeloma treatment including autologous and allogeneic conditioning. Parasitosis with A lumbricoides has a worldwide prevalence of about a billion and is extremely rare in northern Europe. Possibly the patient got infected during a trip to Egypt years before multiple myeloma was diagnosed.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31782899</PMID><DateCompleted><Year>2020</Year><Month>10</Month><Day>02</Day></DateCompleted><DateRevised><Year>2020</Year><Month>10</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1399-3062</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>1</Issue><PubDate><Year>2020</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Transplant infectious disease : an official journal of the Transplantation Society</Title><ISOAbbreviation>Transpl Infect Dis</ISOAbbreviation></Journal><ArticleTitle>Excretion of Ascaris lumbricoides following reduced-intensity allogeneic hematopoietic stem cell transplantation and consecutive treatment with mebendazole.</ArticleTitle><Pagination><MedlinePgn>e13224</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/tid.13224</ELocationID><Abstract><AbstractText>Here, we present the unique case of a 51-year-old German patient with multiple myeloma excreting Ascaris lumbricoides in his stool five weeks after allogeneic hematopoietic stem cell transplantation. Stool analysis remained negative for the presence of eggs, and there was no eosinophilia in the peripheral blood at any time around stem cell transplantation. The patient was commenced on a three-day treatment with mebendazole, which was well tolerated. No serious interactions with the concomitant post-transplant medication or negative effects on the hematopoiesis were observed, and the myeloma still is in complete remission. To our knowledge, this is the first report on excretion of A lumbricoides in the context of allogeneic stem cell transplantation. The case is remarkable with view to the fact that the parasite has supposedly survived all courses of myeloma treatment including autologous and allogeneic conditioning. Parasitosis with A lumbricoides has a worldwide prevalence of about a billion and is extremely rare in northern Europe. Possibly the patient got infected during a trip to Egypt years before multiple myeloma was diagnosed.</AbstractText><CopyrightInformation>© 2019 The Authors. Transplant Infectious Disease published by Wiley Periodicals, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Luber</LastName><ForeName>Verena</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine II, University Hospital of Würzburg, Würzburg, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Hematology and Oncology, Sana Hospital Hof, Hof, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lutz</LastName><ForeName>Mathias</ForeName><Initials>M</Initials><Identifier Source="ORCID">https://orcid.org/0000-0002-2572-5687</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine II, University Hospital of Würzburg, Würzburg, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine A, University Hospital of Münster, Münster, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abele-Horn</LastName><ForeName>Marianne</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute for Hygiene and Microbiology, University of Würzburg, Würzburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Einsele</LastName><ForeName>Hermann</ForeName><Initials>H</Initials><Identifier Source="ORCID">https://orcid.org/0000-0002-7680-0819</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine II, University Hospital of Würzburg, Würzburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grigoleit</LastName><ForeName>Götz Ulrich</ForeName><Initials>GU</Initials><Identifier Source="ORCID">https://orcid.org/0000-0003-0847-8124</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine II, University Hospital of Würzburg, Würzburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mielke</LastName><ForeName>Stephan</ForeName><Initials>S</Initials><Identifier Source="ORCID">https://orcid.org/0000-0002-8325-9215</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine II, University Hospital of Würzburg, Würzburg, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CAST, Department of Laboratory Medicine and Medicine Huddinge, Karolinska Institutet and University Hospital, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>02</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>Denmark</Country><MedlineTA>Transpl Infect Dis</MedlineTA><NlmUniqueID>100883688</NlmUniqueID><ISSNLinking>1398-2273</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>81G6I5V05I</RegistryNumber><NameOfSubstance UI="D008463">Mebendazole</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001196" MajorTopicYN="N">Ascariasis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017164" MajorTopicYN="N">Ascaris lumbricoides</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004534" MajorTopicYN="N" Type="Geographic">Egypt</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005243" MajorTopicYN="N">Feces</DescriptorName><QualifierName UI="Q000469" MajorTopicYN="Y">parasitology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018380" MajorTopicYN="Y">Hematopoietic Stem Cell Transplantation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008463" MajorTopicYN="N">Mebendazole</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009101" MajorTopicYN="N">Multiple Myeloma</DescriptorName><QualifierName UI="Q000469" MajorTopicYN="N">parasitology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010270" MajorTopicYN="N">Parasite Egg Count</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D033581" MajorTopicYN="N">Stem Cell Transplantation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019172" MajorTopicYN="N">Transplantation Conditioning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014184" MajorTopicYN="N">Transplantation, Homologous</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Ascaris lumbricoides
</Keyword><Keyword MajorTopicYN="N">hematopoietic stem cell transplantation</Keyword><Keyword MajorTopicYN="N">mebendazole</Keyword><Keyword MajorTopicYN="N">multiple myeloma</Keyword><Keyword MajorTopicYN="N">mycophenolic acid</Keyword><Keyword MajorTopicYN="N">sirolimus</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>03</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>10</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>11</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>11</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>10</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>11</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31782899</ArticleId><ArticleId IdType="doi">10.1111/tid.13224</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Idris OA, Wintola OA, Afolayan AJ. Helminthiases; prevalence, transmission, host-parasite interactions, resistance to common synthetic drugs and treatment. Heliyon. 2019;5:e01161.</Citation></Reference><Reference><Citation>Omrani VF, Fallahi S, Rostami A, et al. Prevalence of intestinal parasite infections and associated clinical symptoms among patients with end-stage renal disease undergoing hemodialysis. Infection. 2015;43:537-544.</Citation></Reference><Reference><Citation>Palumbo A, Avet-Loiseau H, Oliva S, et al. Revised international staging system for multiple myeloma: a report from international myeloma working group. J Clin Oncol. 2015;33:2863-2869.</Citation></Reference><Reference><Citation>Mai EK, Bertsch U, Durig J, et al. Phase III trial of bortezomib, cyclophosphamide and dexamethasone (VCD) versus bortezomib, doxorubicin and dexamethasone (PAd) in newly diagnosed myeloma. Leukemia. 2015;29:1721-1729.</Citation></Reference><Reference><Citation>Wright JE, Werkman M, Dunn JC, Anderson RM. Current epidemiological evidence for predisposition to high or low intensity human helminth infection: a systematic review. Parasit Vectors. 2018;11:65.</Citation></Reference><Reference><Citation>Lakshmi SP, Palaniappan N, Arunagiri A. Ascariasis: challenges in the diagnosis of single worm disease. J Indian Med Assoc. 2013;111:621-622.</Citation></Reference><Reference><Citation>Khuroo MS. Ascariasis. Gastroenterol Clin North Am. 1996;25:553-577.</Citation></Reference><Reference><Citation>Lamberton PH, Jourdan PM. Human ascariasis: diagnostics update. Curr Trop Med Rep. 2015;2:189-200.</Citation></Reference><Reference><Citation>Mejia R, Nutman TB. Evaluation and differential diagnosis of marked, persistent eosinophilia. Semin Hematol. 2012;49:149-159.</Citation></Reference><Reference><Citation>Sharma M, Showkat A, Somani P. An unusual cause of biliary colic. Gastroenterology. 2017;153:e1-e2.</Citation></Reference><Reference><Citation>Avery RH, Wall LA, Verhoeve VI, Gipson KS, Malone JB. Molecular confirmation of Ascaris suum: further investigation into the zoonotic origin of infection in an 8-year-old boy with loeffler syndrome. Vector Borne Zoonotic Dis. 2018;18:638-640.</Citation></Reference><Reference><Citation>Behm CA, Ovington KS. The role of eosinophils in parasitic helminth infections: insights from genetically modified mice. Parasitol Today. 2000;16:202-209.</Citation></Reference><Reference><Citation>Aleksandra L, Barbara Z, Natalia LA, Danuta KB, Renata GK, Ewa ML. Respiratory failure associated with Ascariasis in a patient with immunodeficiency. Case Rep Infect Dis. 2016;2016:4070561.</Citation></Reference><Reference><Citation>Jurcic JG, Koll B, Brown AE, Crown JP, Yahalom J, Gulati SC. Excretion of Ascaris lumbricoides during total body irradiation. Bone Marrow Transplant. 1994;13:491-493.</Citation></Reference><Reference><Citation>Panic G, Duthaler U, Speich B, Keiser J. Repurposing drugs for the treatment and control of helminth infections. Int J Parasitol Drugs Drug Resist. 2014;4:185-200.</Citation></Reference><Reference><Citation>Cao S, Aboge GO, Terkawi MA, et al. Mycophenolic acid, mycophenolate mofetil, mizoribine, ribavirin, and 7-nitroindole inhibit propagation of Babesia parasites by targeting inosine 5'-monophosphate dehydrogenase. J Parasitol. 2014;100:522-526.</Citation></Reference><Reference><Citation>Azevedo LS, Castro MC, Paula FJ, Ianhez LE, David-Neto E. Mycophenolate mofetil may protect against Pneumocystis carinii pneumonia in renal transplanted patients. Rev Inst Med Trop Sao Paulo. 2005;47:143-145.</Citation></Reference><Reference><Citation>Lutz M, Mielke S. New perspectives on the use of mTOR inhibitors in allogeneic haematopoietic stem cell transplantation and graft-versus-host disease. Br J Clin Pharmacol. 2016;82:1171-1179.</Citation></Reference><Reference><Citation>Khadir F, Shaler CR, Oryan A, et al. Therapeutic control of leishmaniasis by inhibitors of the mammalian target of rapamycin. PLoS Negl Trop Dis. 2018;12:e0006701.</Citation></Reference><Reference><Citation>Mejia P, Trevino-Villarreal JH, Reynolds JS, et al. A single rapamycin dose protects against late-stage experimental cerebral malaria via modulation of host immunity, endothelial activation and parasite sequestration. Malar J. 2017;16:455.</Citation></Reference></ReferenceList></PubmedData></pubmed><affiliations><list><country><li>Allemagne</li><li>Suède</li></country><region><li>Bavière</li><li>District de Basse-Franconie</li><li>District de Münster</li><li>Rhénanie-du-Nord-Westphalie</li><li>Svealand</li></region><settlement><li>Münster</li><li>Stockholm</li><li>Wurtzbourg</li></settlement></list><tree><country name="Allemagne"><region name="Bavière"><name sortKey="Luber, Verena" sort="Luber, Verena" uniqKey="Luber V" first="Verena" last="Luber">Verena Luber</name></region><name sortKey="Abele Horn, Marianne" sort="Abele Horn, Marianne" uniqKey="Abele Horn M" first="Marianne" last="Abele-Horn">Marianne Abele-Horn</name><name sortKey="Einsele, Hermann" sort="Einsele, Hermann" uniqKey="Einsele H" first="Hermann" last="Einsele">Hermann Einsele</name><name sortKey="Grigoleit, Gotz Ulrich" sort="Grigoleit, Gotz Ulrich" uniqKey="Grigoleit G" first="Götz Ulrich" last="Grigoleit">Götz Ulrich Grigoleit</name><name sortKey="Luber, Verena" sort="Luber, Verena" uniqKey="Luber V" first="Verena" last="Luber">Verena Luber</name><name sortKey="Lutz, Mathias" sort="Lutz, Mathias" uniqKey="Lutz M" first="Mathias" last="Lutz">Mathias Lutz</name><name sortKey="Lutz, Mathias" sort="Lutz, Mathias" uniqKey="Lutz M" first="Mathias" last="Lutz">Mathias Lutz</name><name sortKey="Mielke, Stephan" sort="Mielke, Stephan" uniqKey="Mielke S" first="Stephan" last="Mielke">Stephan Mielke</name></country><country name="Suède"><region name="Svealand"><name sortKey="Mielke, Stephan" sort="Mielke, Stephan" uniqKey="Mielke S" first="Stephan" last="Mielke">Stephan Mielke</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Bois/explor/RapamycinFungusV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000122 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000122 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Bois
|area= RapamycinFungusV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:31782899
|texte= Excretion of Ascaris lumbricoides following reduced-intensity allogeneic hematopoietic stem cell transplantation and consecutive treatment with mebendazole.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:31782899" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a RapamycinFungusV1
| This area was generated with Dilib version V0.6.38. |  |